Arm Announces Earnings Release Date for Third Quarter Fiscal Year Ended 2026 Arm Holdings plc (NASDAQ: ARM) will report financial results for the third quarter of fiscal year 2026 on Wednesday, Feb. 4, 2026, after market close. The company will host a conference call via audio webcast at 14:00 Pacific Time (17:00 Eastern Time / 22:00 Greenwich Mean Time) to review its financial results and business outlook. [...]
Everest Group to Hold Fourth Quarter 2025 Earnings Conference Call on Thursday, February 5, 2026 Everest Group, Ltd. (“Everest”) (NYSE: EG) will hold its fourth quarter 2025 earnings conference call on Thursday, February 5, 2026, beginning at 8:00 am Eastern Time. Dial in details can be obtained by completing the registration form available at: https://dpregister.com/sreg/10205413/102ff00e703 The call can be accessed via a live, listen only webcast at www.investors.everestglobal.com where a [...]
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST (1:30 p.m. EST/6:30 p.m. GMT). The live webcast may be accessed under the [...]
LivaNova to Present at J.P. Morgan Healthcare Conference in January December 23, 2025 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time. [...]
Argan, Inc. Reports Third Quarter Fiscal 2026 Results December 4, 2025 Reports Record Backlog of $3.0 Billion
Morningstar Announces Clearer, Simplified Medalist Rating to Empower Investor Success December 4, 2025 Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today announced significant updates to its Morningstar Medalist Rating™, its comprehensive forward-looking rating for managed investments. The updated methodology, which will go live globally in April 2026, is designed to simplify the rating structure, make the rating more transparent for investors, and enhance stability—empowering [...]
IGI President & CEO Waleed Jabsheh to Present at the 17th Annual Southwest IDEAS Investor Conference on November 19, 2025 in Dallas, Texas November 17, 2025 International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that President & CEO Waleed Jabsheh will present at the Southwest IDEAS Investor Conference on Wednesday, November 19, 2025 at The Westin Las Colinas in Dallas, Texas. IGI’s presentation is scheduled to begin at 9.15 am Central Time (10.15 am Eastern time). [...]
Morningstar’s 2026 Outlook Report Delivers Global and Regional Insights for Durable Portfolios November 17, 2025 Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today published its 2026 Outlook, offering an overview of key challenges and opportunities for the year ahead. In a market defined by uncertainty, this year’s report emphasizes the value of preparation over prediction, equipping investors with strategies to focus on fundamentals and help build [...]
Allianz Achieves Record Results and Expects a Full-Year Operating Profit of at Least 17 Billion Euros November 14, 2025 3Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113803211/en/ Double-digit growth in operating profit and shareholders’ core net income Total business volume rises 5.21 percent with contributions from all segments Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income [...]
Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference November 12, 2025 Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 8:00 a.m. ET (1:00 p.m. GMT). The live webcast can be accessed in the Investors [...]